Enhancing safety and outcomes with the newer antithrombotic and antiplatelet agents

This publication has 17 references indexed in Scilit:

• Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Platelet Integrin Glycoprotein IIb/IIIa Blocker Integrelin in Elective Coronary Intervention
  Circulation, 1995
• 1006-43 Hirulog™ vs. Heparin During Percutaneous Transluminal Coronary Angioplasty in Patients with Post-Infarction Angina: Results of the Myocardial Infarction Arm of the Hirulog Angioplasty Trial
  Journal of the American College of Cardiology, 1995
• Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty.
  Circulation, 1994
• The development of hirudin as an antithrombotic drug
  Thrombosis Research, 1994
• Specific Thrombin Inhibitors in Vivo
  Annals of the New York Academy of Sciences, 1994
• Collaborative overview of randomised trials of antiplatelet therapy - II: Maintenance of vascular graft or arterial patency by antiplatelet therapy
  BMJ, 1994
• Safety and efficacy of recombinant hirudin (CGP 39 393) versus heparin in patients with stable angina undergoing coronary angioplasty.
  Circulation, 1993
• Use of a direct antithrombin, hirulog, in place of heparin during coronary angioplasty.
  Circulation, 1993
• Effect of pretreatment with aspirin versus aspirin plus dipyridamole on frequency and type of acute complications of percutaneous transluminal coronary angioplasty
  The American Journal of Cardiology, 1990
• Aspirin and dipyridamole in the prevention of acute coronary thrombosis complicating coronary angioplasty.
  Circulation, 1987